26 results
PRE 14A
VRNA
Verona Pharma Plc
8 Mar 24
Preliminary proxy
4:18pm
LEADERSHIP STRUCTURE AND ROLE IN RISK OVERSIGHT
PERIODIC BOARD EVALUATION
CODE OF BUSINESS CONDUCT AND ETHICS
ANTI-HEDGING POLICY
ATTENDANCE … and a B.B.A. in marketing from IONA College, Hagan School of Business. We believe that Ms. Deschamps’ extensive leadership experience in the healthcare
8-K
EX-99.1
VRNA
Verona Pharma Plc
29 Feb 24
Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
6:08am
of respiratory expertise in leadership roles across the US, China, Europe and Japan. Most recently, he served as CEO at Vectura, and previously as Nordic
8-K
EX-99.1
qf666h7zv l68n
9 Nov 22
Verona Pharma Reports Third Quarter 2022 Financial Results and Provides Corporate Update
6:35am
8-K
EX-99.1
0llyc 7fgirqk
3 May 22
Verona Pharma Reports First Quarter 2022 Financial Results and Provides Corporate Update
6:11am
DEF 14A
drv1jr
19 Mar 21
Definitive proxy
4:02pm
10-K
kudjo
25 Feb 21
Annual report
8:29am
10-K
EX-10.20
5ehci
25 Feb 21
Annual report
8:29am
F-1/A
up3fig6xejm7unberxn
25 Aug 20
Registration statement (foreign) (amended)
4:06pm
F-1
u4cps drtn3
17 Aug 20
Registration statement (foreign)
6:41am
6-K
EX-1.1
0ddmw1btsnnofkjqyg
30 Apr 20
Current report (foreign)
7:34am
6-K
EX-1.2
xq5z pc2x6
10 Mar 20
Current report (foreign)
9:46am